Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Reset all filters
01 1Aventis Pharma Deutschland GmbH Bad Soden DE
02 1BAYER PHARMA AG Berlin DE
03 1CARDINAL BIOSCIENCE LTD Hamilton NZ
04 1Celliance Toronto, Inc. Toronto CA
05 1DSM NUTRITIONAL PRODUCTS LTD BRANCH PENTAPHARM Basel CH
06 1Merck & Co Inc Whitehouse Station US
07 2PENTAPHARM AG Aesch CH
08 2Sigma-Aldrich Corporation Saint Louis US
Reset all filters
01 2Aprotinin concentrated solution
02 1Aprotinin concentrated solution, Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free
03 1Aprotinin, Concentrated solution; Freeze-dried powder
04 1Aprotinin, Freeze-dried powder, Bacterial Endotoxin Free
05 1Aprotinin, Lyophilised powder
06 1Bovine Aprotinin, (Catalogue Number 7107)
07 1Trypsin
08 1Trypsin, Product numbers T5429, T7309 and T8315
09 1Trypsin, TPCK-treated, Product numbers T3053 and T3943
Reset all filters
01 1France
02 1Germany
03 1New Zealand
04 2Switzerland
05 5U.S.A
Reset all filters
01 2Expired
02 4Valid
03 4Withdrawn by Holder
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Aprotinin Concentrated Solution
Certificate Number : R0-CEP 2000-385 - Rev 01
Status : Expired
Issue Date : 2005-02-18
Type : TSE
Substance Number : 579
Aprotinin Concentrated Solution
Certificate Number : R1-CEP 2000-161 - Rev 03
Status : Withdrawn by Holder
Issue Date : 2011-09-15
Type : Chemical and TSE
Substance Number : 579
Certificate Number : R0-CEP 2007-122 - Rev 00
Status : Expired
Issue Date : 2008-03-04
Type : TSE
Substance Number : 580
Bovine Aprotinin, (Catalogue Number 7107)
Certificate Number : R1-CEP 2000-208 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2006-03-07
Type : TSE
Substance Number :
Aprotinin, Concentrated Solution; Freeze-dried P...
Certificate Number : R1-CEP 2000-023 - Rev 03
Status : Valid
Issue Date : 2023-06-27
Type : TSE
Substance Number : 580
Aprotinin Concentrated Solution, Activity: 100 -...
Certificate Number : R1-CEP 2002-095 - Rev 06
Status : Valid
Issue Date : 2023-06-30
Type : Chemical and TSE
Substance Number : 579
Trypsin, TPCK-treated, Product Numbers T3053 And...
Certificate Number : R1-CEP 2000-214 - Rev 04
Status : Valid
Issue Date : 2009-02-06
Type : TSE
Substance Number : 694
Trypsin, Product Numbers T5429, T7309 And T8315
Certificate Number : R1-CEP 2000-218 - Rev 03
Status : Valid
Issue Date : 2009-02-06
Type : TSE
Substance Number : 694
Aprotinin, Freeze-dried Powder, Bacterial Endoto...
Certificate Number : R1-CEP 2002-096 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2009-07-29
Type : Chemical and TSE
Substance Number : 580
Certificate Number : R0-CEP 2000-350 - Rev 02
Status : Withdrawn by Holder
Issue Date : 2005-03-04
Type : TSE
Substance Number : 694
58
PharmaCompass offers a list of Aprotinin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Aprotinin manufacturer or Aprotinin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Aprotinin manufacturer or Aprotinin supplier.
PharmaCompass also assists you with knowing the Aprotinin API Price utilized in the formulation of products. Aprotinin API Price is not always fixed or binding as the Aprotinin Price is obtained through a variety of data sources. The Aprotinin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Antilysin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Antilysin, including repackagers and relabelers. The FDA regulates Antilysin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Antilysin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Antilysin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Antilysin supplier is an individual or a company that provides Antilysin active pharmaceutical ingredient (API) or Antilysin finished formulations upon request. The Antilysin suppliers may include Antilysin API manufacturers, exporters, distributors and traders.
click here to find a list of Antilysin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Antilysin CEP of the European Pharmacopoeia monograph is often referred to as a Antilysin Certificate of Suitability (COS). The purpose of a Antilysin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Antilysin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Antilysin to their clients by showing that a Antilysin CEP has been issued for it. The manufacturer submits a Antilysin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Antilysin CEP holder for the record. Additionally, the data presented in the Antilysin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Antilysin DMF.
A Antilysin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Antilysin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Antilysin suppliers with CEP (COS) on PharmaCompass.
We have 6 companies offering Antilysin
Get in contact with the supplier of your choice: